Pfizer has begun a Phase 2 and 3 clinical trial of its Covid-19 antiviral treatment, Paxlovid, in children ages 6 to 17, the company said Wednesday in a news release.

(SOURCE) https://www.cnn.com/2022/03/09/health/pfizer-paxlovid-pediatric-trial/index.html